Literature DB >> 9737470

Concurrence of anaphylaxis and acute heparin-induced thrombocytopenia in a patient with heparin-induced antibodies.

R L Hewitt1, D L Akers, C A Leissinger, J I Gill, R H Aster.   

Abstract

We report the occurrence of acute heparin-induced thrombocytopenia in a patient with anaphylaxis that began immediately after an intravenous bolus dose of unfractionated heparin. This case report is the first to document the concurrence of these 2 reactions to heparin. An abrupt fall in platelet count was documented immediately after the anaphylactic response. Study results for antibodies characteristic of heparin-induced thrombocytopenia were positive in 2 assays: serotonin release assay and heparin platelet factor 4 enzyme-linked immunosorbent assay. The patient's antibody was exclusively immunoglobulin G. Any explanation for the relationship between the antibody response observed and the histamine release remains speculative.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737470     DOI: 10.1016/s0741-5214(98)70146-6

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Heparin "hitts" again.

Authors:  Federico Goti; Wolfgang Korte; Duri Gianom; Marco Decurtins
Journal:  Eur J Clin Pharmacol       Date:  2002-02       Impact factor: 2.953

Review 2.  [Thrombocytopathy and blood complications in uremia].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2006-04       Impact factor: 1.704

3.  Early recognition is the key to success: pulseless electrical activity (PEA) as a manifestation of heparin-induced anaphylactoid reaction.

Authors:  Apoorva Jayarangaiah; Narendranath Epperla
Journal:  BMJ Case Rep       Date:  2015-11-04

4.  COVID-19 and Kounis Syndrome: Deciphering Their Relationship.

Authors:  Nicholas G Kounis; Ioanna Koniari; Cesare de Gregorio
Journal:  Balkan Med J       Date:  2021-05       Impact factor: 2.021

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.